Transcripts

MiNK Therapeutics (INKT) earnings call transcripts

Earnings call transcripts for MiNK Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter around moving Agent 797 toward comparative ARDS evidence while building an international access pathway and stressing early data remain unproven.

    Aug 13, 2026Positive0.45